Heterogeneity of G6PD deficiency prevalence in Mozambique: A school-based cross-sectional survey in three different regions CIBS-25/013 CIBS IRB00002657 IRB

Malaria Journal

Volumn 16, Issue 1, 2017, Pages

  Galatas, Beatriz ^a,b   Mabote, Lurdes ^a   Simone, Wilson ^a   Matambisso, Gloria ^a   Nhamussua, Lidia ^a   Mañú Pereira, María Del Mar ^b   Menéndez, Clara ^a,b   Saute, Francisco ^a   Macete, Eusebio ^a,c   Bassat, Quique ^a,b,d   Alonso, Pedro ^b   Aide, Pedro ^a,e  

^a Manhiça Health Research Center   (Mozambique)

^b UNIVERSITY OF BARCELONA   (Spain)

^c MINISTRY OF HEALTH   (Mozambique)

^d INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^e INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

Author keywords

Deficiency; Glucose 6 phosphate dehydrogenase; Mozambique

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; ANTIMALARIAL AGENT;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME ACTIVITY; FEMALE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYSIS; HUMAN; MALE; MOZAMBIQUE; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; CHILD; GENETICS; GEOGRAPHY; SCHOOL; YOUNG ADULT;

ADOLESCENT; ANTIMALARIALS; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; GEOGRAPHY; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; MALE; MOZAMBIQUE; PREVALENCE; SCHOOLS; YOUNG ADULT;

EID: 85009865180     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-016-1674-y     Document Type: Article

References (27)

1. Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64-74.
2. Luzzatto L. Genetics of red cells and susceptibility to malaria. Blood. 1979;54:961-76.
3. Orimadegun AE, Sodeinde O. Glucose-6-phosphate dehydrogenase status and severity of malarial anaemia in Nigerian children. J Infect Dev Ctries. 2011;5:792-8.
4. Roth EF, Raventos-Suarez C, Rinaldi A, Nagel RL. Glucose-6-phosphate dehydrogenase deficiency inhibits in vitro growth of Plasmodium falciparum. Proc Natl Acad Sci USA. 1983;80:298-9.
5. Guindo A, Fairhurst RM, Doumbo OK, Wellems TE, Diallo DA. X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria. PLoS Med. 2007;4:e66.
6. Manjurano A, Sepulveda N, Nadjm B, Mtove G, Wangai H, Maxwell C, et al. African glucose-6-phosphate dehydrogenase alleles associated with protection from severe malaria in heterozygous females in Tanzania. PLoS Genet. 2015;11:e1004960.
7. Luzzatto L. G6PD deficiency: a polymorphism balanced by heterozygote advantage against malaria. Lancet Haematol. 2015;2:e400-1.
8. Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012;9:e1001339.
9. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009;42:267-78.
10. Beutler E. G6PD: population genetics and clinical manifestations. Blood Rev. 1996;10:45-52.
11. Van Malderen C, Van Geertruyden J-P, Machevo S, González R, Bassat Q, Talisuna A, et al. Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria. Malar J. 2012;11:139.
12. Schuurman M, van Waardenburg D, Costa JD, Niemarkt H, Leroy P. Severe hemolysis and methemoglobinemia following fava beans ingestion in glucose-6-phosphatase dehydrogenase deficiency - case report and literature review. Eur J Pediatr. 2009;168:779-82.
13. Beutler E. G6PD deficiency. Blood. 1994;84:3613.
14. Howes RE, Battle KE, Satyagraha AW, Baird JK, Hay SI. G6PD deficiency. Adv Parasitol. 2013;81:133-201.
15. Torres HA, Barnett BJ, Arduino RC. Use of fosamprenavir, a sulfa-containing protease inhibitor, in HIV-infected patients with glucose-6-phosphate dehydrogenase deficiency. Clin Infect Dis. 2007;44:887-8.
16. Chan TYK. Co-trimoxazole-induced severe hemolysis: the experience of a large general hospital in Hong Kong. Pharmacoepidemiol Drug Saf. 1997;6:89-92.
17. WHO. Guidelines for the treatment of malaria. Geneva: World Health Organization; 2015.
18. Horton J, Brueckner R. A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis. Clin Infect Dis. 2001;33:1968-74.
19. Nieuwenhuis F, Wolf B, Bomba A, De Graaf P. Haematological study in Cabo Delgado province, Mozambique; sickle cell trait and G6PD deficiency. Trop Geogr Med. 1986;38:183-7.
20. Aguilar R, Moraleda C, Achtman AH, Mayor A, Quintó L, Cisteró P, et al. Severity of anaemia is associated with bone marrow haemozoin in children exposed to Plasmodium falciparum. Br J Haematol. 2014;164:877-87.
21. Reys L, Manso C, Stamatoyannopoulos G. Genetic studies on southeastern Bantu of Mozambique. I. Variants of glucose-6-phosphate dehydrogenase. Am J Hum Genet. 1970;22:203.
22. Tinley KE, Loughlin AM, Jepson A, Barnett ED. Evaluation of a rapid qualitative enzyme chromatographic test for glucose-6-phosphate dehydrogenase deficiency. Am J Trop Med Hyg. 2010;82:210-4.
23. Kim S, Nguon C, Guillard B, Duong S, Chy S, Sum S, et al. Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PLoS ONE. 2011;6:e28357.
24. Howes RE, Dewi M, Piel FB, Monteiro WM, Battle KE, Messina JP, et al. Spatial distribution of G6PD deficiency variants across malaria-endemic regions. Malar J. 2013;12:418.
25. National Malaria Control Programme. National malaria indicator survey, Mozambique (MIS-2007). Ministry of Health.
26. Ministerio da Saúde (MISAU), Instituto Nacional de Estadística (INE), ICF Internacional. Moçambique Inquerito Demográfico e de Saúde 2011. Calverton: MISAU, INE, ICFI.
27. Tantular IS, Iwai K, Lin K, Basuki S, Horie T, Htay HH, et al. Field trials of a rapid test for G6PD deficiency in combination with a rapid diagnosis of malaria. Trop Med Int Health. 1999;4:245-50.